http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2863176-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2534bb9f13460c6429c25acf8df25d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5c121269689cbab9b3a4548b15caf3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06
filingDate 2012-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_598cd1e57f409944fddffd41af5a468f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ae8d384b7f9138f3f68a1b87554bf32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7534b5b63fbc35703c8309b5d78a1214
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf721f7c5ef77822a741ad236b357cdd
publicationDate 2013-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2863176-A1
titleOfInvention Therapeutic agent and preventive agent for demyelinating disease
abstract The purpose of the present invention is to provide a novel therapeutic agent and preventive agent for demyelinating disease. The present invention is a therapeutic agent and a preventive agent for demyelinating disease that contain as an active ingredient a 2-phenylthiazole compound represented by formula (I) or a medically acceptable salt thereof.
priorityDate 2011-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414078673
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1051

Total number of triples: 31.